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A B S T R A C T Cetiedil has been reported to relieve
painful crises in sickle cell anemia and to have anti-
sickling properties in vitro. The drug alters neither
oxygen affinity nor the solubility of deoxyhemoglobin
S. Because the viscosity of the erythrocyte interior and
the kinetics ofgelation are dependent on the concentra-
tion of hemoglobin, we postulated that cetiedil might
inhibit sickling by modifying erythrocyte sodium or
potassium movements in a manner that would increase
cell water content and thus dilute the cell hemoglobin.
The drug has two such effects: it inhibits the specific
increase in potassium permeability that follows a rise in
cytoplasmic calcium concentration and it causes a rise
in passive sodium movements. These effects are further
evidence that cell ion and water movements may be
important in the process ofsickling and suggest a mech-
anism for the results reported with cetiedil.
INTRODUCTION
Cetiedil, one of a family of compounds synthesized
as smooth muscle relaxants, relieves pain from claudi-
cation and Raynaud's phenomenon (1). In addition,
cetiedil has been reported to decrease the duration
and intensity of sickle cell crises, although this study
was not performed in a controlled, double-blinded
fashion (2). This effect may be more than vascular since
a statistically significant decrease in sickle forms has
also been observed when hemoglobin S-containing
erythrocytes are deoxygenated in the presence of
cetiedil (1, 3). Concentrations of cetiedil used in these
in vitro studies were comparable to those achieved
during in vivo administration (1). As the action of the
drug differs from other antisickling agents, affecting
neither the solubility nor the oxygen affinity of hemo-
globin S (3), we postulated that cetiedil might exert
A portion of this work has been published in abstract form
(1980. Clin. Res. 28: 823a; 1981. Clin. Res. 29: 330a).
Address reprints requests to Dr. Lee R. Berkowitz.
Received for publication 6 May 1981 and in revised form
3 July 1981.
J. Clin. Invest. The American Society for Clinical Investiga
its beneficial effect by lowering the concentration of
hemoglobin S within the erythrocyte.
The viscosity of the erythrocyte interior is largely a
function of hemoglobin concentration. Thus, a fall in
cell water content impairs erythrocyte deformability
(4). This effect is magnified in the deoxygenated
sickle erythrocyte because a rise in cell hemoglobin
concentration greatly accelerates the rate at which
hemoglobin S polymerizes (5). There are also several
lines of evidence to suggest that the sickle erythrocyte
becomes dehydrated in the process of deoxygenation
(6-9). Finally, in vitro and in vivo evidence indicate
that hypotonic conditions, by lowering intracellular
hemoglobin S concentration, inhibit the tendency to
sickle (10, 11). For these reasons a drug that in-
creased sodium permeability or inhibited a preexistent
tendency for potassium loss would, by preventing
cellular dehydration, preserve the deformability of the
sickle erythrocyte.
The present studies were designed to test the in vitro
effect of cetiedil on ion and water movements across
the membranes of normal and sickle erythrocytes.
Two effects were found. Passive Na permeability,
examined by both net and unidirectional flux studies,
is increased. A preexistent tendency for K loss, studied
by exposing erythrocytes to conditions known to gen-
erate a selective increase in K permeability, ATP
depletion followed by Ca exposure (12), is inhibited
by cetiedil. These properties that prevent cellular
dehydration offer a potential explanation for the re-
ported antisickling effects of cetiedil.
METHODS
Blood from hematologically normal volunteers or patients
with sickle cell anemia who had not been transfused for
a minimum of 6 mo was drawn into heparin-rinsed syringes
and used within 30 min ofcollection. For experiments evaluat-
ing the net flux of Na and K, the plasma and buffy coat were
discarded and the remaining cells were washed four times at
10,000 g in 10 vol of a Na wash containing, NaCl 155 mM;
Hepes 5 mM; pH 7.4 at 37°C. A small aliquot ofthese cells was
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reserved for the base-line measurement of Na, K, and water
(the "0 time" sample) and the remaining cells were suspended
in buffered saline solutions, the composition of which are
detailed in the figure legends. For Na, K, and water
determination, the washed cells were centrifuged at 40,000 g
in specially constructed lucite cell water tubes with a narrow
well at the bottom for collection of the cell button. Na and
K measurements were performed by flame photometry, on
packed, weighed aliquots of the cells. Results were expressed
as milliequivalents per kilogram of dry cell solid. The water
content was measured by drying a known weight of wet
cells to constant weight at 90°C. Details of these procedures
have been previously published (13).
All incubations were carried out at 37°C in stoppered
flasks under air in a water-bath shaker set at 100 oscillations/
min over a traverse of 1 in. At the timepoints indicated
on the figures, an aliquot of each suspension was removed
and centrifuged at 10,000 g. Following removal of the super-
natant by aspiration, the cells were washed four times in the
Na wash solution and then processed for Na, K, and water
content.
The unidirectional movement of Na was evaluated using
22Na. 22Na was obtained as 22NaCl from New England Nuclear,
Boston, Mass. The cells were washed four times in 10 vol
of Na wash as described above and added to the appro-
priate solutions. After a 5-min equilibration period at 37°C,
22Na was added in concentration sufficient to give 50,000 dpm.
At the indicated times, aliquots were removed and centrifuged
at 40,000 g in cell water tubes. The supernatant was separated
and the packed cells hemolyzed with distilled water contain-
ing 10 ,ul of Triton X-100. Both the supernatant and the hemo-
lyzed cells were counted in a Packard gamma counter. (Pack-
ard Instrument Co. Inc., Downers Grove, Ill.). Hemoglobin
















cells as cyanmethemoglobin complex at 540 OD. The influx
was calculated from the ratio of cell counts to supernatant
counts and expressed as millimoles Na per gram hemo-
globin per hour. The trapped extracellular space was es-
timated from the counts in the hemolyzed cells of the "0
time" sample.
To examine the effect of cetiedil on Ca-dependent K per-
meability, cells were washed in 10 vol of a K wash con-
taining, KCI 150 mM, Hepes 5 mM; pH 7.4 at 37°C. Measure-
ments of Na, K, and cell water were performed ("fresh"
sample), following which ATP depletion was carried out by
exposing cells for 60 min at 37°C to a solution containing,
KCI 145 mM, Hepes 10 mM, inosine 10 mM, iodoacetate 1
mM; pH 7.4. The cells were again washed in the K wash to
remove all traces of the inhibitor, and Na, K, and cell water
measurements were done ("0 time" sample). This repeated
use of K-rich solutions prevented initiation of K loss during
these preparative steps. The cells were then placed in Na-
rich solutions, the composition of which are indicated in the
figure legends, and incubated at 37°C. Aliquots of the
suspension were removed at certain timepoints, washed with
the Na wash, and processed for Na, K, and water content.
The cetiedil used in these studies was provided in powder
form by Dr. Gerard Pilley of Innothera Pharmaceuticals,
Arcueil, France. It was suspended in a concentrated form
in 95% ethanol and an identical volume of the vehicle was
added to all control flasks.
Each experiment was carried out with both normal and sickle
erythrocytes. Figs. 1, 2, 4, and 6 plot the mean and standard
error of the mean of four identical experiments performed
twice with normal erythrocytes and twice with sickle erythro-
cytes. The experiments illustrated in Figs. 3 and 5 were also
repeated a minimum offour times. As these figures show dose-
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FIGURE 1 The effect of cetiedil (0.1 mM) on ion and water content of erythrocytes during a
24-h incubation. Erythrocytes were divided into four flasks and incubated in a solution containing,
NaCl 145 mM, KCI 5 mM, Na2HPO4 2.5 mM, Hepes 10 mM, glucose 10 mM; pH 7.5 at 37°C.
Cetiedil 0.1 mM and ouabain 0.1 mM were added as indicated on the figure.
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FIGURE 2 The effect of cetiedil (0.1, 0.25 and 0.5 mM) on ion and water content of erythrocytes
during a 24-h incubation. Erythrocytes were divided into three flasks and incubated in a solution
containing, NaCl 145 mM, KCl 5 mM, Na2HPO4 2.5 mM, Hepes 10 mM, glucose 10 mM; pH
7.5 at 37°C. Cetiedil was added to each flask at the indicated concentration.
shown. Each of these two figures is a representative dose-
response curve using sickle erythrocytes. The patterns ofdose-
response achieved with normal erythrocytes were the same.
RESULTS
The effect of cetiedil on the ion and water content of
erythrocytes during a 24-h net flux study is shown in
Fig. 1. This experiment was performed in the pres-
ence and absence of ouabain. During the 24-h period,
exposure to cetiedil alone at a concentration of 0.1 mM
caused no change in Na, K, or water content. Erythro-
cytes in a physiologic solution plus ouabain showed the
expected gain of Na and loss of K. Similar ion changes
occurred when cetiedil was added to ouabain, but no
additional effect was noted. At cetiedil concentrations
above 0.1 mM, erythrocytes exhibited an increase in Na
content even in the absence of ouabain (Fig. 2). At a
cetiedil concentration of 0.5 mM, samples could only
be obtained up to 6 h after which total hemolysis
occurred, making longer incubations invalid.
To investigate further the etiology ofthe Na gain seen
at higher concentrations of cetiedil, a 22Na influx was
performed. All samples were exposed to 0.1 mM oua-
bain to eliminate active Na efflux via the Na-K pump.
Concentrations of cetiedil identical to those in Fig. 2
(0.1, 0.25, and 0.5 mM) were used. At 0.1 mM, the
Na influx was identical to a control flask where no
cetiedil was present. At cetiedil concentrations > 0.1
mM, Na influx was increased in a dose-dependent
fashion (Fig. 3).
The next series of experiments was performed to
evaluate the effect of cetiedil on erythrocyte K per-
meability. Erythrocytes were exposed to in vitro condi-
tions known to produce a selective increase in K per-
meability. ATP depletion was accomplished with inosine
and iodoacetate. After 1-h exposure to the inhibitor,
cell ATP levels were < 1%. The erythrocytes were then
placed into one ofthree Na solutions: (a) a solution with
EGTA, a Ca chelator; (b) a solution with EGTA plus
an excess of Ca; or (c) a solution with EGTA, an excess
of Ca, and cetiedil 0.1 mM. Na, K, and water content
were measured at 30, 60, and 120 min (Fig. 4). Cells
exposed to an excess of Ca showed marked K loss and
cell dehydration, changes which were not observed if
Ca was omitted from the incubation vessel. This Ca-
dependent K and water loss was totally inhibited by
cetiedil.
The dosage dependency of cetiedil on inhibition

































FIGURE 3 The effect of cetiedil on unidirectional Na influx
in erythrocytes. Erythrocytes were divided into four flasks
and incubated in a solution containing, NaCl 145 mM, KCI 5
mM, Na2HPO4 2.5 mM, Hepes 10 mM, glucose 10 mM; pH 7.5
at 37°C. Ouabain 0.1 mM was present in all flasks. Cetiedil
was added in the concentrations indicated. After a 5 min
equilibration period, 22Na was added and the rate of 22Na
influx was measured.
of K and water loss is seen in Fig. 5. Erythrocytes
were ATP-depleted and exposed to graded concentra-
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FIGURE 4 The effect of cetiedil on Ca-mediated K per-
meability in the erythrocyte. Erythrocytes were incubated for
1 h in a solution containing, KCl 145 mM, Hepes 10 mM,
inosine 10 mM, iodoacetate 1 mM; pH 7.5 at 37°C. The erythro-
cytes were then placed into one of three solutions as indi-
cated on the figure: (1) NaCl 150 mM, Hepes 10 mM, EGTA
0.25 mM (2) NaCl 150 mM, Hepes 10 mM, EGTA 0.25 mM,
CaCl2 2 mM; (3) NaCl 150 mM, Hepes 10mM, EGTA 0.25mM,
CaCl2 2 mM, cetiedil 0.1 mM.
in all solutions. A graded dose-response was seen with
maximum inhibition of K and water loss at 0.1 mM
cetiedil. Little effect was seen at 10 uM cetiedil.
The final experiment tested the ability of cetiedil to
inhibit K and water loss once initiated (Fig. 6). After
ATP depletion, all erythrocytes were placed for 60 min
in a solution containing an excess of Ca. At the end of
this hour, K and water loss had begun. The cells were
then divided into two flasks and cetiedil, at a concentra-
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FIGURE 5 The dosage dependency of cetiedil on Ca-mediated K permeability in the erythro-
cyte. Erythrocytes were incubated for 1 h in a solution containing, KCL 145 mM, Hepes 10 mM,
inosine 10 mM, iodoacetate 1 mM; pH 7.5 at 37°C. The erythrocytes were then placed into six
flasks in a solution containing, NaCl 150 mM, Hepes 10 mM, EGTA 0.25 mM, CaCl2 2 mM; pH
7.5 at 37°C. Cetiedil was added to each flask at the concentration indicated on the figure.
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FIGuRE 6 The effect of cetiedil on Ca-mediated K permeability, once initiated, in the erythro-
cyte. Erythrocytes were incubated for 1 h in a solution containing, KCl 145 mM, Hepes 10
mM, inosine 10 mM, iodoacetate 1 mM; pH 7.5 at 370C. Erythrocytes were next incubated
for 1 h in a solution containing, NaCl 150 mM, Hepes 10 mM, EGTA 0.25 mM, CaCl2 2 mM. Ery-
throcytes were then divided into 2 flasks and 0.1 mM cetiedil added to one flask (dashed line).
tion of 0.1 mM, was added to one. Those cells not
exposed to cetiedil continued to lose K and water.
Unlike the control flask, however, K loss and cell
dehydration were abruptly terminated as soon as the
erythrocytes were exposed to cetiedil.
DISCUSSION
The foregoing experiments suggest that cetiedil might
exert its antisickling effect by preventing an increase
in the concentration of cytoplasmic hemoglobin
through an influence on erythrocyte ion and water
content. Because the concentration of hemoglobin
within all erythrocytes is the major determinant of cyto-
plasmic viscosity, a rise in hemoglobin concentration
results in a fall in cell deformability (14). An increase
in hemoglobin concentration exerts a second, par-
ticularly deleterious effect upon sickle erythrocytes. In
these cells the rate at which hemoglobin S aggregates
following deoxygenation is enormously influenced by
the cell hemoglobin concentration (5).
Since hemoglobin is an impermeant species, its
intracellular concentration is determined by the water
content ofthe erythrocyte, which in turn is a function of
the number of osmotically active particles within the
cell. Because K is the major intracellular cation, a
permeability defect specific for K and not Na will result
in the loss of cellular ions and water (15). Several
lines of evidence suggest that the sickle erythrocyte
becomes dehydrated during cycles of deoxygenation
and that this loss of cell water with its resultant increase
in cytoplasmic viscosity and impaired cellular de-
formability is the result of K loss (6-9). The mech-
anism by which such an increase in K permeability
might develop is less certain. An attractive hypothesis
would suggest that repeated cycles of deoxygenation
promote the intracellular accumulation of Ca ions
(16, 17). A rise in the Ca content in the erythrocyte
is known to cause K loss by creating K-specific channels
in the erythrocyte membrane (12, 18). Data supporting
such a sequence of events in the sickle erythrocyte
include the following: (a) increased Ca content of the
sickle erythrocyte (17, 19); (b) loss of K from sickle
erythrocytes during deoxygenation (6); and (c) shrink-
age of sickle erythrocytes upon deoxygenation. (9).
One could easily envision as the end result of this
process, the severely dehydrated, energy-depleted,
irreversibly sickled cell (8, 20).
Unlike other antisickling agents, cetiedil does not
appear to interact with hemoglobin S since oxygen
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affinity and solubility remain unchanged (3). The drug,
however, exerts two distinct effects on monovalent
cation permeability, each of which would tend to
prevent cell dehydration. Either effect of cetiedil
would inhibit the increase in cell hemoglobin con-
centration observed in sickle erythrocytes and thus
preserve their intrinsic deformability. Such an hy-
pothesis is consistent with the "swelling" noted by
Asakura et al. (3).
It is reasonable to speculate that the mechanism of
action of a potential antisickling agent involves a
change in erythrocyte membrane permeability rather
than a modification of the hemoglobin S molecule. Be-
fore assuming clinical relevance for these in vitro
studies with cetiedil, however, a similar reduction
in cell dehydration must be demonstrated in vivo.
Controlled clinical trials, which include these in vivo
measurements of erythrocyte cation and water content,
will attempt to correlate physiologic effects on the sickle
erythrocyte with amelioration of sickle cell crises.
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